Stomach adenocarcinoma (STAD), thyroid carcinoma (THCA), HNSCC, lung squamous cell carcinoma (LUSC), liver hepatocellular carcinoma (LIHC), esophageal carcinoma (ESCA), colon adenocarcinoma (COAD), and cholangiocarcinoma (CHOL) all showed considerably higher DKK1 expression. Here, DKK1 is linked to cholangiocarcinoma.